Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Comparative Effectiveness Randomized Trial to Assess a Transseptal Approach to Left Ventricular Ablation Compared to Retrograde to Prevent Cerebral Emboli & Neurocognitive Decline in Adults With Ventricular Tachycardia/Premature Ventricular Contractions

NCT03946072 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03946072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03946072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Comparative Effectiveness Randomized Trial to Assess a Transseptal Approach to Left Ventricular Ablation Compared to Retrograde to Prevent Cerebral Emboli & Neurocognitive Decline in Adults With Ventricular Tachycardia/Premature Ventricular Contractions
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
July 2, 2019
Completion date
November 25, 2023
Enrollment
153 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

neurocognitive dysfunction